New COVID-19 strain raises concerns

Recent scientific reports, relayed by the British newspaper “Mirror”, raise new concerns about the existence of coronavirus strains that are more resistant to current vaccines and more difficult to stop.

Among these strains is FLiRT, which is estimated to currently represent 25% of COVID-19 cases in the United States.

A similar scenario is unfolding in the United States with another strain called KP.1.1, which represents 7.5% of COVID-19 cases in the country. These reports raise global concerns about the spread of these strains around the world, further complicating international efforts to combat the pandemic.

The spokesperson for the US Centers for Disease Control and Prevention (CDC) comments on these developments by stating that viruses are constantly evolving through mutations. These changes can make viruses more transmissible or more resistant to current treatments and vaccines.

In the face of this evolution, experts predict a significant increase in the number of COVID-19 cases, putting considerable strain on global health systems that are still struggling to meet the challenges of the pandemic.

Despite the evolution of the virus, the main symptoms of COVID-19 remain the same, including fever, persistent cough, loss of smell or taste, as well as shortness of breath and sore throat.

As developments in the world of viruses continue, the importance of rapid action and international cooperation to address the new challenges posed in controlling the COVID-19 pandemic and protecting the health of humanity around the world continues to grow.